Alexandros Makriyannis

Chair, Chemistry and Chemical Biology, Northeastern University
When
4th-5th Mar 2020
Where
Rotterdam, The Netherlands
Postilion Convention Centre WTC
Pharmaceutical and biotech development of cannabinoid-based drugs has recently become a highly active and fertile ground for the generation of a new class of regulated therapeutics. The combination of advancements in our understanding the underlying biology of the endocannabinoid system, with the production of natural and synthetic cannabinoid products, is now being shown to have myriad therapeutic value for unmet medical conditions. The inaugural International Cannabinoid-Based Drug Discovery and Development (iCBD3) Congress, co-located with the 8th Plant Genomics and Gene Editing Congress, March 4-5 in Rotterdam, Netherlands will explore an array of drug targets, therapies, manufacturing processes, regulatory frameworks, clinical studies and market opportunities for cannabinoid-based pharmaceuticals.
This programme creates a collaborative environment in which you can create enduring relationships across the full range of cannabinoid pharmaceutical discovery and development.
Track One: Cannabinoid Research and Discovery
Genomics, molecular biology and target validation in disease
Medicinal chemistry, pharmacology and biosynthesis
Track Two: Cannabinoid Development and Manufacturing
Regulatory standards, clinical studies and opportunities in primary markets
Bioprocessing, analytics and manufacturing
Director of Science, GHM Europe; Director, Cannabinoid Advice Netherlands
CEO, Drug Science (Project TWENTY21)
Founder & CEO, Kanabo Research
Chairman & CEO, Scientus Pharma
CEO, CMO and Director, Emerald Bioscience
CSO, Kalytera Therapeutics
Founder, Hazekamp Herbal
Founder & Chief Strategist, i+, Business Development Studios; Co-Founder, Cistron Corp
Development Lead, ART27.13, Artelo Biosciences LLP; Pharmacy Lead Centre, Medicinal Cannabis UK
Senior Investigator, NIAA, NIH
Chair, Chemistry and Chemical Biology, Northeastern University
Senior Program Director, Tetra Bio-Pharma
Founding Board Member, Zelda Therapeutics
Crop Specialist, Wageningen UR
Director & Head, Medicinal Chemistry, Corbus Pharma
Medicinal Chemist, Pharma Research, F. Hoffmann-La Roche
CSO, Oxford Cannabinoid Technologies
Research Director, the Institute of Biomolecular Chemistry of the National Research Council (ICB-CNR)
Professor, Molecular Physiology, Leiden University
Associate Professor, Molecular Pharmacology, University of Nottingham
Vice President, R&D, Willow Bioscience
Group Leader, Medicinal Chemistry Leibniz-Institut für Molekulare Pharmakologie
CSO, Lavvan
CEO and CSO, Synendos Therapeutics AG
CSO, Panag Pharma
Professor and Chair of Biochemistry and Molecular Biology, University of Rome
Director of Science, GHM Europe; Director, Cannabinoid Advice Netherlands
CEO, Drug Science (Project TWENTY21)
Founder & CEO, Kanabo Research
Chairman & CEO, Scientus Pharma
CEO, CMO and Director, Emerald Bioscience
CSO, Kalytera Therapeutics
Founder, Hazekamp Herbal
Founder & Chief Strategist, i+, Business Development Studios; Co-Founder, Cistron Corp
Development Lead, ART27.13, Artelo Biosciences LLP; Pharmacy Lead Centre, Medicinal Cannabis UK
Senior Investigator, NIAA, NIH
Chair, Chemistry and Chemical Biology, Northeastern University
Senior Program Director, Tetra Bio-Pharma
Founding Board Member, Zelda Therapeutics
Crop Specialist, Wageningen UR
Director & Head, Medicinal Chemistry, Corbus Pharma
Medicinal Chemist, Pharma Research, F. Hoffmann-La Roche
CSO, Oxford Cannabinoid Technologies
Research Director, the Institute of Biomolecular Chemistry of the National Research Council (ICB-CNR)
Professor, Molecular Physiology, Leiden University
Associate Professor, Molecular Pharmacology, University of Nottingham
Vice President, R&D, Willow Bioscience
Group Leader, Medicinal Chemistry Leibniz-Institut für Molekulare Pharmakologie
CSO, Lavvan
CEO and CSO, Synendos Therapeutics AG
CSO, Panag Pharma
Professor and Chair of Biochemistry and Molecular Biology, University of Rome
The inaugural International Cannabinoid-Based Drug Discovery and Development Congress will explore an array of drug targets, therapies, manufacturing processes, international regulatory frameworks, clinical studies and market opportunities for cannabinoid-based pharmaceuticals.
For speaker opportunities, please contact: Kip@globalengage.co.uk
Download the AgendaPostilion Convention Centre WTC Rotterdam
Beursplein 37
3011 AA Rotterdam
The Netherlands
Postillion Convention Center WTC Rotterdam is the accommodation for exhibitions, national and international conferences, business and / or festive events, meetings and courses. The Convention Center features a 3,500m² exhibition floor and offers unique exposure possibilities.
Postillion Convention Center WTC Rotterdam can be easily reached by car and public transport. The location features its own (paid) parking garage in the heart of Rotterdam where guests can park their car. The location is also easily accessible by public transport, the metro or tram station is right in front.
Early Bird Offers
A 25% discount is offereed on the Industry and Academic fee. Valid until 29 November 2019.
A 15% discount will be offered until 31 January 2020.
Full fee is €999 for industry and €599 Academic and Not for Profit.
Multiple bookings
Contact maria@globalengage.co.uk to discus booking two of more places.
Not applicable for solution provider companies or compatible with any other offers or discount codes.
Option 1 – Please phone +44 (0) 1865 671957 ext. 207 and we will take your details over the phone
Option 2 – Please complete the form below to pay online
*Offer not open to solution providers who should contact sponsorship@globalengage.co.uk to discuss alternative options.
849.00€
This 15% discounted fee is available until January 31. Standard registration for those not in the categories below.
509.00€
This 15% discount fee is available until January 31
1,299.00€
This fee applies to organisations offering services and/or business & technology solutions and also to business consultants.
Our sponsorship packages offer a wide range of attendance options to suit your budget and business needs in order to maximize return on investment.
If there is any other way you would like to sponsor or increase branding for your company at the event, please get in touch and we will be able to offer you a bespoke service.
Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings, held during breakout sessions from the main conference agenda. Our conference team will be available at the sessions to ensure all your meetings take place on time.
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience.
Market to our event database and / or increase brand awareness through taking a poster position or sponsoring one of the refreshment breaks, lunches, drinks receptions or poster sessions. This can be supplemented by branding options such as placing your logo on the attendee lanyards or conference bags.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas where all refreshment breaks and lunches take place, as well as the networking drinks reception at the end of day one.
Options include:
For further details please contact
Tony Couch or Nick Best
Telephone +44 (0) 1865 849841 or
email: tony@globalengage.co.uk or nick@globalengage.co.uk
Call us on +44 (0)1865 849 841
For details on attendees, packages and new opportunities, please contact our sponsorship team who will quickly provide everything you need to assess the conference for yourself.
Bentham Science Publishers is a major STM journal publisher of 130 plus print and online journal. Out of these, 40 journals have already registered good IMPACT FACTORS as per Journal Citation Reports® 2017. These titles have extensive readership mostly in Europe and North America. For a detailed profile please visit our website at http://www.benthamscience.com. Besides, Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Our eBooks provide professionals, academicians, corporate researchers, graduates and undergraduates worldwide with the most current information in their subject areas of interest. Our eBooks are also available in the ePub and Kindle formats besides the PDF edition here http://ebooks.benthamscience.com/.
Bentham Science is offering 20% discounts on purchasing eBooks and subscriptions on Journals to delegates attending the conference. TO AVAIL, QUOTE “BSPCNF2019” at www.eurekaselect.com or email at marketing@benthamscience.net. For more information click here
×Biomall.in is an online e-commerce marketplace that ships lab reagents, lab equipment & supplies worldwide. Visit Biomall.in now to buy laboratory, life science & diagnostic products from India.
×Cardea’s mission is to transform the life science and healthcare industries by collaborating with a consortium of Innovation Partners in order to create novel products and solutions for instant biological insights. The company provides their Innovation Partners with a breakthrough graphene-based digital biosensor hardware, software, and molecular infrastructure which enables application of advanced biosensors to any biological system. This makes the technology the ideal conduit to enable the future Internet of Biology.
×Infuzes.com is the largest b2b cannabis industry database with company profiles, events, and conferences, an integrated smart tracker, and global analytics as a resource for cannabis professionals offering essential insights. Also giving institutional and retail investors access to real-time, high-quality, reliable market and pricing data.
×Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace.
×Pharma Journalist is a paramount B2b online magazine platform exhibiting targeted and succinct information concerning the world of Pharmaceutical Industry, keeping a tab on the updated and latest updates and trends concerning the field.
×PharmaVOICE magazine provides readers with insightful and thought-provoking commentary about the challenges and trends impacting the life-sciences industry in a multiple-perspective format through articles covering a range of issues from molecule through market. PharmaVOICE’s more than 41,000 BPA-qualified subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
×